WallStSmart
VANI

Vivani Medical Inc.

NASDAQ: VANI · HEALTHCARE · BIOTECHNOLOGY

$1.20
-7.81% today

Updated 2026-06-05

Market cap
$97.45M
P/E ratio
P/S ratio
EPS (TTM)
$-0.40
Dividend yield
52W range
$1 – $2
Volume
0.3M

Vivani Medical Inc. (VANI) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20122013201420152016201720182019202020212022202320242025
Operating cash flow$-15.32M$-17.43M$-17.09M$-20.55M$-25.07M$-23.95M$-29.81M$-27.63M$-7.62M$-10.95M$-18.79M$-23.70M$-20.79M$-24.32M
Capital expenditures$196083.00$246004.00$560351.00$762000.00$490000.00$265000.00$163000.00$493000.00$150000.00$572000.00$338000.00$887000.00$556000.00$1.17M
Depreciation
Stock-based comp$907862.00$769896.00$1.47M$2.69M$3.37M$3.78M$3.59M$2.92M$1.04M$1.67M$1.30M$1.86M$1.61M$1.48M
Free cash flow$-15.52M$-17.67M$-17.65M$-21.31M$-25.56M$-24.21M$-29.97M$-28.12M$-7.77M$-11.52M$-19.13M$-24.59M$-21.34M$-25.49M
Investing cash flow
Financing cash flow
Dividends paid
Share repurchases
Debt repayment
Net change in cash

Frequently asked questions

How much free cash flow does VANI generate?

VANI produced $-25.49M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is VANI's balance sheet healthy?

VANI holds $16.23M in cash and equivalents against — in long-term debt, on $15.73M of shareholder equity. That debt is best read against the cash flow the business throws off each year.